Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

To understand how the Mayo Clinic became a superior healthcare brand, I talked with Leonard Berry, PhD, to understand their ...

Whether you like golf or Hello Kitty®, binge-watch Friends® re-runs, or simply love to take your pup everywhere you go, the Washington Nationals have a date on the calendar just for you. The Nationals ...

The FDA defines a Class 1 recall as “a situation in which there is a reasonable probability that the use of or exposure to a ...

The medication will be sold under the brand name Journavx for $15.50 per pill, according to Vertex Pharmaceuticals, the company that developed the new drug. The FDA's sign-off on the medication ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

While America retains a gold standard for airline safety, there are stresses on the US air travel system that have been ...